Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE

Korea University82 enrolled

Overview

Arteriosclerosis is a dynamic inflammatory disorder. Recently, FDG-PET CT is emerging diagnostic tool of non-invasive technique to detect vulnerable atherosclerotic plaque. And there are arising evidence that sRAGE(soluble Receptor for Advanced glycation End Product) is correlated with metabolic risk. So the investigators will investigate association between sRAGE and FDG-PET uptake in large artery in healthy patient.

Study Type

OBSERVATIONAL

Enrollment

Conditions

sRAGE Level SUV and TBR Levels in FDG PET

Eligibility

Sex: ALLMin age: 16 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis od type 2 DM Exclusion Criteria: * Type 1 DM * Gestational Diabetes * Severe Liver or Renal disease * Diagnosis of cancer * Trauma * Acute infection or inflammatory disease * Acute vasculitis or history of vasculitis * Pregnant or Lactating women * Dyslipidemia(active state) * Cardiovascular disease or history of CVD * Chronic obstructive pulmonary disease * Any patient by judge of investigator

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.